Symptomatic methemoglobinemia in a patient with metastatic clear cell renal cell carcinoma treated with pembrolizumab and axitinib combination therapy: a case report

被引:0
|
作者
T. Anders Olsen
Dylan J. Martini
Sean T. Evans
Jamie M. Goldman
Mehmet Asim Bilen
机构
[1] Emory University School of Medicine,Department of Hematology and Medical Oncology
[2] Winship Cancer Institute of Emory University,undefined
关键词
Case report; Methemoglobinemia; Immunotherapy; Adverse events and renal cell carcinoma;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [11] Pembrolizumab and axitinib induced pathological complete response in metastatic clear cell renal cell carcinoma with inferior vena cava thrombus: A case report
    Wong, Ryan
    Rose, Tracy L.
    Tan, Hung-Jui
    Hansen, Christina
    Wobker, Sara E.
    Bjurlin, Marc
    SAGE OPEN MEDICAL CASE REPORTS, 2025, 13
  • [12] PATHOLOGIC COMPLETE RESPONSE OF CLEAR CELL RENAL CELL CARCINOMA TO PEMBROLIZUMAB AND AXITINIB IN A PATIENT WITH BILATERAL RENAL MASSES
    Ermolovich, Eugene
    Gandrabur, Alina
    Monte, Andrew
    Goueli, Basem
    Rutkowski, John
    JOURNAL OF UROLOGY, 2021, 206 : E861 - E861
  • [13] A case of complete response to avelumab plus axitinib combination therapy for metastatic clear cell renal cell carcinoma in a kidney undergoing dialysis
    Shiomi, Ei
    Goto, Yuta
    Hisano, Mizuki
    Ito, Rento
    Moriwaka, Makoto
    Ikarashi, Daiki
    Maekawa, Shigekatsu
    Kato, Renpei
    Kanehira, Mitsugu
    Ujiie, Takashi
    Obara, Wataru
    IJU CASE REPORTS, 2024, 7 (02) : 148 - 151
  • [14] Pembrolizumab-Induced Rhabdomyolysis in a Clear Cell Renal Cell Carcinoma Patient: A Case Report
    Altermanini, Mohammad
    Ali, Khaled
    Alwassiti, Wisam
    Almohtasib, Suliman
    Omar, Nabil E.
    Zafar, Abdulaziz
    CASE REPORTS IN ONCOLOGY, 2023, 16 (01): : 728 - 733
  • [15] Hemodiafiltration and plasma levels of axitinib in a patient with metastatic renal clear cell carcinoma
    Kopecky, Jindrich
    Ticha, Alena
    Janeckova, Hana
    Melichar, Bohuslav
    BIOMEDICAL PAPERS-OLOMOUC, 2018, 162 (04): : 335 - 339
  • [16] Sinus Bradycardia With Pauses Owing to Axitinib/Pembrolizumab in a Metastatic Renal Cell Carcinoma Patient
    McGreevy, Joseph W.
    Ghous, Ghulam
    Shoukat, Hafiz Muhammad Hassan
    Zafar, Muhammad Usman
    Tarar, Zahid Ijaz
    AMERICAN JOURNAL OF THERAPEUTICS, 2023, 30 (03) : E304 - E305
  • [17] Pembrolizumab combined with axitinib in the treatment of skin metastasis of renal clear cell carcinoma to nasal ala:A case report
    Shuai Dong
    Yang-Chun Xu
    Yuan-Chen Zhang
    Jian-Xin Xia
    Yan Mou
    World Journal of Clinical Cases, 2023, (09) : 2104 - 2109
  • [18] Pembrolizumab combined with axitinib in the treatment of skin metastasis of renal clear cell carcinoma to nasal ala: A case report
    Dong, Shuai
    Xu, Yang-Chun
    Zhang, Yuan-Chen
    Xia, Jian-Xin
    Mou, Yan
    WORLD JOURNAL OF CLINICAL CASES, 2023, 11 (09) : 2104 - 2109
  • [19] Outcomes With Combination Pembrolizumab and Axitinib in Second and Further Line Treatment of Metastatic Renal Cell Carcinoma
    Dizman, Nazli
    Austin, Matthew
    Considine, Bryden
    Jessel, Shlomit
    Schoenfeld, David
    Merl, Man Yee
    Hurwitz, Michael
    Sznol, Mario
    Kluger, Harriet
    CLINICAL GENITOURINARY CANCER, 2023, 21 (02) : 221 - 229
  • [20] Comparative Effectiveness of Front-Line Ipilimumab and Nivolumab or Axitinib and Pembrolizumab in Metastatic Clear Cell Renal Cell Carcinoma
    Zarrabi, Kevin K.
    Handorf, Elizabeth
    Miron, Benjamin
    Zibelman, Matthew R.
    Anari, Fern
    Ghatalia, Pooja
    Plimack, Elizabeth R.
    Geynisman, Daniel M.
    ONCOLOGIST, 2023, 28 (02): : 157 - 164